Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026

TORONTO, May 14, 2026 (GLOBE NEWSWIRE) --  Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, is pleased to announce that the TULSA Procedure™ will be highlighted in four oral presentations at the upcoming American Urological Association's (“AUA”) Annual Meeting in Washington, DC, in the session titled “Prostate Cancer: Localized: Ablative Therapy II” on May 16th from 1:00-3:00 p.m. ET. TULSA Procedure Talks at AUA2026 Ram A.

GlobeNewsWire • May 14, 2026

Industrials Momentum ETF (PRN) Touches a New 52-Week High

PRN hits a new 52-week high as momentum in industrial stocks accelerates, fueled by domestic manufacturing strength.

Zacks Investment Research • May 7, 2026

Profound Medical Reports Strong First Quarter 2026 Financial Results

– Quarterly results marked by 104% revenue growth and improved operating performance – – Company issues full-year 2026 revenue guidance – – Announces Humana is now covering the TULSA Procedure™ – TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, today reported financial results for the first quarter ended March 31, 2026. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars and are presented in accordance with U.S. generally accepted accounting principles (U.S. GAAP).

GlobeNewsWire • May 7, 2026

Should You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?

If you're interested in broad exposure to the Industrials - Broad segment of the equity market, look no further than the Invesco Dorsey Wright Industrials Momentum ETF (PRN), a passively managed exchange traded fund launched on October 12, 2006.

Zacks Investment Research • Apr 14, 2026

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Survey data underscored how the war in the Middle East has already had a material impact on economic growth around the world. Drilling down deeper, the data showed weaker growth trends were recorded across all major industries globally.

Seeking Alpha • Apr 12, 2026

PRN: Industrials Dashboard For March

All industrial subsectors are significantly overvalued, except transportation. The Invesco Dorsey Wright Industrials Momentum ETF offers superior fundamentals and historical returns versus the sector benchmark XLI. PRN is well-suited for long-term or tactical allocations, though XLI remains preferable for short-term traders due to superior liquidity.

Seeking Alpha • Mar 17, 2026

Profound Medical Corp. (PRN:CA) Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer Transcript

Profound Medical Corp. (PRN:CA) Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer Transcript

Seeking Alpha • Mar 13, 2026

Profound Medical Corp. (PRN:CA) Q4 2025 Earnings Call Transcript

Profound Medical Corp. (PRN:CA) Q4 2025 Earnings Call Transcript

Seeking Alpha • Mar 6, 2026

Profound Medical Corp. (PRN:CA) Q3 2025 Earnings Call Transcript

Profound Medical Corp. ( PRN:CA ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Stephen Kilmer - Investor Relations Rashed Dewan Mathieu Burtnyk - President Thomas Tamberrino - Chief Commercial Officer Arun Menawat - Chairman of the Board & CEO Conference Call Participants Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division John McAulay - Stifel, Nicolaus & Company, Incorporated, Research Division Michael Freeman - Raymond James Ltd., Research Division Presentation Operator Good day, and thank you for standing by.

Seeking Alpha • Nov 14, 2025

Profound Medical Corp. (PROF) Q2 2025 Earnings Call Transcript

Profound Medical Corp. (NASDAQ:PROF ) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Arun Swarup Menawat - Chairman of the Board & CEO Mathieu Burtnyk - President Rashed Dewan - Chief Financial Officer Stephen Kilmer - Corporate Participant Investor Relations - Corporate Participant Thomas Tamberrino - Chief Commercial Officer Conference Call Participants Benjamin Charles Haynor - Lake Street Capital Markets, LLC, Research Division Douglas W. Loe - Leede Financial Inc., Research Division John Glenn McAulay - Stifel, Nicolaus & Company, Incorporated, Research Division Michael W.

Seeking Alpha • Aug 15, 2025